CN102988488A - Pharmaceutical composition for treating hypertension - Google Patents

Pharmaceutical composition for treating hypertension Download PDF

Info

Publication number
CN102988488A
CN102988488A CN 201110278425 CN201110278425A CN102988488A CN 102988488 A CN102988488 A CN 102988488A CN 201110278425 CN201110278425 CN 201110278425 CN 201110278425 A CN201110278425 A CN 201110278425A CN 102988488 A CN102988488 A CN 102988488A
Authority
CN
China
Prior art keywords
parts
pharmaceutical composition
hypertension
radix
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 201110278425
Other languages
Chinese (zh)
Inventor
冉兵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201110278425 priority Critical patent/CN102988488A/en
Publication of CN102988488A publication Critical patent/CN102988488A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the technical field of traditional Chinese medicine, and provides a pharmaceutical composition for treating hypertension, which can effectively reduce blood pressure and improves the cure rate of the hypertension. The invention is realized by the following technical scheme: the pharmaceutical composition for treating hypertension comprises the raw materials based on parts by weight: 10-30 parts of liquorice, 10-30 parts of notopterygium root, 10-30 parts of divaricate saposhnikovia root, 5-10 parts of cortex magnoliae officinalis, 15-30 parts of radix bupleuri, 5-10 parts of ligusticum wallichii, 10-15 parts of rhizoma atractylodis, 5-15 parts of gypsum, 20-30 parts of ganoderma applanatum and 10-30 parts of chrysanthemum. The pharmaceutical composition can be used for treating the hypertension; and clinical test proves that the pharmaceutical composition has the effective rate of 100% and the cure rate of 91% for the hypertension.

Description

A kind ofly treat hypertensive pharmaceutical composition
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of hypertensive pharmaceutical composition for the treatment of.
Background technology
Hypertension (hypertensive disease) is a kind of chronic disease take the lasting rising of arteriotony as main manifestations.The blood pressure standard of using according to World Health Organization (WHO) (Who) suggestion is: all normal adult systolic pressures should be less than or equal to 140mmHg (18.6kPa), and diastolic pressure is less than or equal to 90mmHg (12kPa).That is systolic pressure is between 141-159mmHg (18.9-21.2kPa), and diastolic pressure is borderline hypertension between 91-94mmHg (12.1-12.5kPa).The traditional Chinese medical science it has been generally acknowledged that hypertension belongs to " dizzy ", " headache " sick category; Mainly by feelings will internal injury, hepatic and renal YIN deficiency yang hyperactivity or eating and drinking without temperance, due to the turbid heap soil or fertilizer over and around the roots of expectorant stagnates; Control this often take nourishing YIN and subduing the hyperactivity of liver-YANG or expectorant damp eliminating etc. as rule for the treatment of.
At present, by the interim blood pressure lowering of Western medicine, cure rate is very low usually for hypertension.
Summary of the invention
In view of this, the invention provides a kind of hypertensive pharmaceutical composition for the treatment of, can effectively reduce blood pressure, improve hypertensive cure rate.
The objective of the invention is to be achieved through the following technical solutions: a kind ofly treat hypertensive pharmaceutical composition, comprise the raw material of following weight portion: Radix Glycyrrhizae 10-30, Rhizoma Et Radix Notopterygii 10-30, Radix Saposhnikoviae 10-30, Cortex Magnoliae Officinalis 5-10, Radix Bupleuri 15-30, Rhizoma Chuanxiong 5-10, Rhizoma Atractylodis 10-15, Gypsum Fibrosum 5-15, Ganoderma applanatum (Pers. Ex Wallr) Pat. 20-30, Flos Chrysanthemi 10-30.
Further, the raw material that comprises following weight portion: Radix Glycyrrhizae 25, Rhizoma Et Radix Notopterygii 25, Radix Saposhnikoviae 25, Cortex Magnoliae Officinalis 7, Radix Bupleuri 18, Rhizoma Chuanxiong 9, Rhizoma Atractylodis 10, Gypsum Fibrosum 7, Ganoderma applanatum (Pers. Ex Wallr) Pat. 30, Flos Chrysanthemi 20.
A kind of hypertensive pharmaceutical composition for the treatment of of the present invention through clinical trial, reaches 100% for hypertensive effective percentage, and cure rate reaches 91%.
The specific embodiment
Embodiment 1
Use the raw material of Chinese medicine of following weight portion:
Radix Glycyrrhizae 10, Rhizoma Et Radix Notopterygii 30, Radix Saposhnikoviae 30, Cortex Magnoliae Officinalis 5, Radix Bupleuri 15, Rhizoma Chuanxiong 5, Rhizoma Atractylodis 15, Gypsum Fibrosum 15, Ganoderma applanatum (Pers. Ex Wallr) Pat. 20, Flos Chrysanthemi 30.
Decoct with water three times, each 1 hour, filter merging filtrate, oral four times of every day.
Embodiment 2
Radix Glycyrrhizae 30, Rhizoma Et Radix Notopterygii 10, Radix Saposhnikoviae 10, Cortex Magnoliae Officinalis 10, Radix Bupleuri 30, Rhizoma Chuanxiong 10, Rhizoma Atractylodis 13, Gypsum Fibrosum 5, Ganoderma applanatum (Pers. Ex Wallr) Pat. 27, Flos Chrysanthemi 10.
Decoct with water three times, each 1 hour, filter merging filtrate, oral four times of every day.
Embodiment 3
Radix Glycyrrhizae 25, Rhizoma Et Radix Notopterygii 25, Radix Saposhnikoviae 25, Cortex Magnoliae Officinalis 7, Radix Bupleuri 18, Rhizoma Chuanxiong 9, Rhizoma Atractylodis 10, Gypsum Fibrosum 7, Ganoderma applanatum (Pers. Ex Wallr) Pat. 30, Flos Chrysanthemi 20.
Decoct with water three times, each 1 hour, filter merging filtrate, oral four times of every day.
Below be clinical trial:
(1) patient's situation:
Be diagnosed as hypertensive patient, blood pressure is higher than 150/95mmHg.Patient age is 50~75 years old, every group of 100 examples, male 50 examples wherein, women 50 examples.
(2) therapeutic process:
Decoct with water three times, each 1 hour, filter merging filtrate, oral four times of every day.Be 90 days the course for the treatment of.
(3) the clinical statistics evaluation criterion is:
Cure: blood pressure is lower than 140/90mmHg.
Effectively: blood pressure stabilization descends.
Invalid: blood pressure still is higher than 150/95mmHg.
Group The example number Healing/cure rate Effectively/effective percentage Invalid/inefficiency
Embodiment 1 100 86/86% 100/100% 0/0%
Embodiment 2 100 85/85% 100/100% 0/0%
Embodiment 3 100 91/91% 100/100% 0/0%

Claims (2)

1. the hypertensive pharmaceutical composition for the treatment of is characterized in that: the raw material that comprises following weight portion: Radix Glycyrrhizae 10-30, Rhizoma Et Radix Notopterygii 10-30, Radix Saposhnikoviae 10-30, Cortex Magnoliae Officinalis 5-10, Radix Bupleuri 15-30, Rhizoma Chuanxiong 5-10, Rhizoma Atractylodis 10-15, Gypsum Fibrosum 5-15, Ganoderma applanatum (Pers. Ex Wallr) Pat. 20-30, Flos Chrysanthemi 10-30.
2. a kind of hypertensive pharmaceutical composition for the treatment of as claimed in claim 1 is characterized in that: the raw material that comprises following weight portion: Radix Glycyrrhizae 25, Rhizoma Et Radix Notopterygii 25, Radix Saposhnikoviae 25, Cortex Magnoliae Officinalis 7, Radix Bupleuri 18, Rhizoma Chuanxiong 9, Rhizoma Atractylodis 10, Gypsum Fibrosum 7, Ganoderma applanatum (Pers. Ex Wallr) Pat. 30, Flos Chrysanthemi 20.
CN 201110278425 2011-09-19 2011-09-19 Pharmaceutical composition for treating hypertension Pending CN102988488A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110278425 CN102988488A (en) 2011-09-19 2011-09-19 Pharmaceutical composition for treating hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110278425 CN102988488A (en) 2011-09-19 2011-09-19 Pharmaceutical composition for treating hypertension

Publications (1)

Publication Number Publication Date
CN102988488A true CN102988488A (en) 2013-03-27

Family

ID=47917914

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110278425 Pending CN102988488A (en) 2011-09-19 2011-09-19 Pharmaceutical composition for treating hypertension

Country Status (1)

Country Link
CN (1) CN102988488A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104116794A (en) * 2014-07-28 2014-10-29 山东中医药大学附属医院 Traditional Chinese medicine for adjuvant treatment on obesity related hypertension
CN105832819A (en) * 2016-06-18 2016-08-10 练燕华 Traditional Chinese medicine for treating hypertension

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104116794A (en) * 2014-07-28 2014-10-29 山东中医药大学附属医院 Traditional Chinese medicine for adjuvant treatment on obesity related hypertension
CN105832819A (en) * 2016-06-18 2016-08-10 练燕华 Traditional Chinese medicine for treating hypertension

Similar Documents

Publication Publication Date Title
CN104547496B (en) A kind of Chinese medicine composition to moisten the lung and relieve the cough and preparation method thereof
CN102225169B (en) Traditional Chinese preparation for treating dental ulcer
CN101983675A (en) Traditional Chinese medicine composition for treating asthma and preparation method thereof
CN101991699A (en) Traditional Chinese medicine for treating stomach fire toothache and aphthous stomatitis
CN103705878B (en) One treats migraine Chinese medicine preparation
CN101259242B (en) Medicine for treating allergic rhinitis
CN102988488A (en) Pharmaceutical composition for treating hypertension
CN104667251A (en) Foot bath composition for treating cold and preparation method of foot bath composition
CN1879749A (en) Medicinal heath wine
CN103041323A (en) Chinese medicinal liniment for treating alopecia
CN105749216A (en) Traditional Chinese medicine wine for treating hypertension and preparation method thereof
CN105311460A (en) Traditional Chinese medicine for treating vascular neuralgia headache
CN100374133C (en) Medicine for treating mammary gland hyperplasia
CN104225291A (en) Traditional Chinese medicine for treating intermenstrual aphthous stomatitis due to yin-deficiency and fire-hyperactivity syndromes
CN103721053A (en) Traditional Chinese medicine preparation for treating senile hypothyroidism
CN102949509A (en) Pure traditional Chinese medical health protection syrup for clearing lung heat and stopping cough and preparation method thereof
CN102293922B (en) Medicament for treating onychomycosis
CN100540043C (en) A kind of treatment hypertension drug
CN104225189A (en) Traditional Chinese medicine for treating intermenstrual aphthous stomatitis due to stomach-heat fumigation syndrome
CN106389704A (en) Medicine oil for treating onychomycosis and preparing method thereof
CN105056053A (en) Pharmaceutical preparation for treating leuconychia
CN105106768A (en) Traditional Chinese medicine for treating bedsore
CN104940562A (en) Traditional Chinese medicine composition for treating tinnitus
CN104888112A (en) Medicine for treating recurrent oral ulceration
CN103316221A (en) Traditional Chinese medicine composition for treating gastrohelcosis

Legal Events

Date Code Title Description
DD01 Delivery of document by public notice

Addressee: Ran Bing

Document name: Notification of Passing Preliminary Examination of the Application for Invention

C06 Publication
PB01 Publication
DD01 Delivery of document by public notice

Addressee: Ran Bing

Document name: Notification of Publication of the Application for Invention

DD01 Delivery of document by public notice

Addressee: Ran Bing

Document name: Notification of before Expiration of Request of Examination as to Substance

DD01 Delivery of document by public notice

Addressee: Ran Bing

Document name: Notification that Application Deemed to be Withdrawn

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130327